Sutro Biopharma, Inc. (STRO)
25.29
+2.79
(+12.40%)
USD |
NASDAQ |
Mar 06, 16:00
25.24
-0.05
(-0.20%)
After-Hours: 20:00
Sutro Biopharma Free Cash Flow : -225.11M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| GT Biopharma, Inc. | -12.91M |
| Rhythm Pharmaceuticals, Inc. | -156.63M |
| Crinetics Pharmaceuticals, Inc. | -383.68M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -38.19M |
| Cash from Investing (Quarterly) | 39.99M |
| Cash from Financing (Quarterly) | 0.102M |
| Free Cash Flow Per Share (Quarterly) | -4.529 |
| Free Cash Flow to Equity (Quarterly) | -46.30M |
| Free Cash Flow to Firm (Quarterly) | -28.77M |
| Free Cash Flow Yield | -32.88% |